BCS and IVIVC Based Biowaivers

The term bioweber applies to the regulatory approval process when a document (application) is approved based on evidence of equivalence other than in vivo bioequivalence testing. For solid oral dosage forms, Bioweber is generally based on dissolution tests. • BCS is a scientific framework for classifying drug substances based on water solubility and intestinal permeability. In combination with drug lysis, BCS takes into account three major factors that determine the rate and extent of absorption of solid oral IR dosage forms: lysis, solubility, and intestinal permeability.


    Related Conference of BCS and IVIVC Based Biowaivers

    July 04-05, 2023

    39th World Pharmacology and Therapeutics Forum

    Paris, France
    October 16-17, 2023

    19th Annual Congress on Pharmacology and Toxicology

    Tokyo, Japan

    BCS and IVIVC Based Biowaivers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in